Latest Insider Transactions at Repare Therapeutics Inc. (RPTX)
This section provides a real-time view of insider transactions for Repare Therapeutics Inc. (RPTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Repare Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Repare Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2022
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
141,103
+18.62%
|
-
|
|
Jun 06
2022
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
851,202
-61.29%
|
-
|
|
Jun 06
2022
|
Versant Vantage I, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
151,202
+26.47%
|
-
|
|
Jun 06
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,869
+0.06%
|
$89,297
$13.21 P/Share
|
|
Jun 03
2022
|
Davis Jerel Director |
SELL
Open market or private sale
|
Indirect |
750,000
-20.37%
|
$9,000,000
$12.25 P/Share
|
|
Jun 03
2022
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
750,000
-20.37%
|
$9,000,000
$12.25 P/Share
|
|
Jun 03
2022
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
750,000
-20.37%
|
$9,000,000
$12.25 P/Share
|
|
Jun 03
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
644,044
+7.4%
|
$7,728,528
$12.29 P/Share
|
|
Jun 02
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,186,045
+13.9%
|
$13,046,495
$11.68 P/Share
|
|
May 18
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
420,000
+5.04%
|
$3,360,000
$8.5 P/Share
|
|
Mar 15
2022
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
533
-1.14%
|
$5,863
$11.3 P/Share
|
|
Jan 19
2022
|
Bvf Partners L P > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
997,961
+11.07%
|
$13,971,454
$14.1 P/Share
|
|
Dec 10
2021
|
Maria Koehler EVP, CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
48,511
+16.24%
|
$97,022
$2.24 P/Share
|
|
Nov 23
2021
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
46,041
+35.57%
|
$46,041
$1.94 P/Share
|
|
Nov 16
2021
|
Thomas Civik |
BUY
Open market or private purchase
|
Direct |
7,500
+50.0%
|
$210,000
$28.08 P/Share
|
|
Nov 15
2021
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-83.19%
|
$540,000
$27.54 P/Share
|
|
Sep 07
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
887
-0.03%
|
$29,271
$33.93 P/Share
|
|
Sep 07
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
887
-0.03%
|
$29,271
$33.93 P/Share
|
|
Sep 03
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,197
-0.22%
|
$244,698
$34.0 P/Share
|
|
Sep 03
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,197
-0.22%
|
$244,698
$34.0 P/Share
|
|
Sep 02
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
16,424
-0.5%
|
$558,416
$34.24 P/Share
|
|
Sep 02
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
16,424
-0.5%
|
$558,416
$34.24 P/Share
|
|
Sep 01
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
12,968
-0.39%
|
$427,944
$33.98 P/Share
|
|
Sep 01
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
12,968
-0.39%
|
$427,944
$33.98 P/Share
|
|
Aug 31
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
8,472
-0.26%
|
$279,576
$33.94 P/Share
|
|
Aug 31
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
8,472
-0.26%
|
$279,576
$33.94 P/Share
|
|
Aug 30
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
6,697
-0.2%
|
$221,001
$33.92 P/Share
|
|
Aug 30
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
6,697
-0.2%
|
$221,001
$33.92 P/Share
|
|
Aug 27
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,093
-0.21%
|
$234,069
$33.94 P/Share
|
|
Aug 27
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,093
-0.21%
|
$234,069
$33.94 P/Share
|
|
Aug 26
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
4,283
-0.13%
|
$145,622
$34.52 P/Share
|
|
Aug 26
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
4,283
-0.13%
|
$145,622
$34.52 P/Share
|
|
Aug 25
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,082
-0.21%
|
$240,788
$34.34 P/Share
|
|
Aug 25
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,082
-0.21%
|
$240,788
$34.34 P/Share
|
|
Aug 24
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
4,039
-0.12%
|
$137,326
$34.07 P/Share
|
|
Aug 24
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
4,039
-0.12%
|
$137,326
$34.07 P/Share
|
|
Aug 23
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
7,094
-0.21%
|
$241,196
$34.06 P/Share
|
|
Aug 23
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
7,094
-0.21%
|
$241,196
$34.06 P/Share
|
|
Aug 18
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
5,860
-0.08%
|
$193,380
$33.99 P/Share
|
|
Aug 18
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
2,930
-0.08%
|
$96,690
$33.99 P/Share
|
|
Aug 17
2021
|
David P Bonita |
SELL
Open market or private sale
|
Indirect |
34,796
-0.52%
|
$1,183,064
$34.12 P/Share
|
|
Aug 17
2021
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
17,398
-0.52%
|
$591,532
$34.12 P/Share
|
|
Aug 16
2021
|
Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-21.77%
|
$510,000
$34.21 P/Share
|
|
Aug 05
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
4,539
-100.0%
|
-
|
|
Aug 05
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
4,539
+50.0%
|
-
|
|
Aug 05
2021
|
Versant Vantage I, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
152,071
-39.68%
|
-
|
|
Aug 05
2021
|
Davis Jerel Director |
SELL
Other acquisition or disposition
|
Indirect |
156,610
-79.89%
|
-
|
|
Aug 05
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Indirect |
4,539
+50.0%
|
-
|
|
Aug 05
2021
|
Davis Jerel Director |
BUY
Other acquisition or disposition
|
Direct |
19
+0.16%
|
-
|
|
Aug 05
2021
|
Versant Ventures V, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
156,610
-79.89%
|
-
|